Report Scope:
In this report, the market has been segmented based on route of administration, therapy type and region. The report provides an overview of the global type 2 diabetes treatment market and analyses market trends. Using 2021 as the base year, it provides estimated market data for the forecast period of 2022 to 2027. Revenue forecasts for this period are segmented based on route of administration, therapy type and geography. Market values have been estimated based on the total revenue of type 2 diabetes therapies providers.
The report covers the market for type 2 diabetes treatment with regard to the therapy type across different regions. It also highlights major trends and challenges that affect the market and the vendor landscape. It estimates the global market for type 2 diabetes treatment in 2021, and then provides projections for the expected market size through 2027.
The scope of the study includes the various types of medicines involved in type 2 diabetes treatment and management. Blood glucose monitoring, diagnostic systems and devices, and insulin-delivery devices used in the treatment of type 2 diabetes, however, have been excluded from this study.
Report Includes:
- A comprehensive overview of the global market for the treatment of type 2 diabetes
- Analyses of the global and regional market trends, with historic revenue data from 2019 to 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2027
- Understanding of the current and future market potential for this innovation driven market, and areas of focus to forecast the market into various segments and sub-segments
- Discussion of the industry growth driving factors and challenges that will shape the market for type 2 diabetes treatment as the basis for projecting demand in the next few years (2022-2027)
- Estimation of the actual market size and revenue forecast for global type 2 diabetes treatment market, and corresponding market share analysis by therapy type, route of administration, end user, and region
- Holistic review of the COVID-19 pandemic implications on the global market for treatment of type 2 diabetes
- Review of the patent grants and patent applications on type 2 diabetes treatment solutions and related technologies
- Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues
Summary:
Type 2 diabetes, the most common form of diabetes, is a chronic and progressive condition in which the body does not make or use insulin normally, leading to high levels of glucose (sugar) in the blood. Type 2 diabetes is one of the greatest modern health challenges. It impacts every country and contributes to millions of deaths annually, and the number of people who suffer from this disorder is rising across all regions. According to the International Diabetes Federation (IDF), in 2021, more than REDACTED people had type 2 diabetes, and this number will reach more than REDACTED by 2045. The drivers influencing the increase in diabetes include the aging population, increasing urbanization in underdeveloped countries, sedentary lifestyles and greater consumption of unhealthy foods linked with obesity. There is currently no cure for type 2 diabetes, but losing weight, eating healthy foods and being active can help prevent, delay and manage diabetes. Several classes of medications and/or therapies have been developed to help people with type 2 diabetes to control their blood sugar.
The global market for type 2 diabetes treatment was estimated to be $REDACTED in 2021. It is projected the type 2 diabetes treatment market will grow at a compound annual growth rate (CAGR) of REDACTED%, and it is forecast to reach $REDACTED by 2027. An expanding patient population, accelerating innovation and presence of significant unmet need in type 2 diabetes treatment are some of the key factors driving the growth of the current treatment market. Given the high unmet need in treatment, healthcare companies are pushing the boundaries of research and science to improve type 2 diabetes care, fueling market growth. Loss of exclusivity, genericization, pricing pressure and evolving regulatory scenarios, however, are hindering market growth.
In this report, the global type 2 diabetes treatment market has been segmented based on route of administration, therapy type and geography. The route of administration segment has been categorized into injectable therapies and oral medications. The oral medications segment, which currently constitutes a larger share of the market, was estimated to be valued at $REDACTED in 2022. It is estimated the oral medications market for type 2 diabetes treatment will grow at a CAGR of REDACTED%, and it is forecast to reach $REDACTED by 2027. The injectable therapies market is further divided into insulin therapy and glucagon-like peptide-1 (GLP-1) therapy. The oral medications market is further segmented into dipeptidyl peptidase-4 (DPP-4) inhibitors, sodium-glucose cotransporter-2 (SGLT2) inhibitors, (GLP-1) receptor agonists and other oral antidiabetic medications (OADs).
The therapy type segment has been categorized into insulin therapy and non-insulin therapies. The non-insulin therapies market dominated the type 2 diabetes treatment market, with a value of $REDACTED in 2021. This market is projected to reach $REDACTED in 2027.
Type 2 Diabetes Treatment: Global Market Outlook
Table of Contents
Chapter 1 Market Outlook
1.1 Market Snapshot
Chapter 2 Executive Summary
Chapter 3 Market Overview
3.1 Type 2 Diabetes Overview
3.1.1 What is Type 2 Diabetes?
3.1.2 Prevalence and Epidemiology of Type 2 Diabetes
3.1.3 Diagnosing Type 2 Diabetes
3.1.4 Treatment for Type 2 Diabetes
3.2 Market Drivers
3.2.1 Rising Prevalence of Diabetes
3.2.2 Next Generation of Type 2 Diabetes Treatment
3.2.3 High Unmet Need
3.2.4 Premium Pricing
3.2.5 Collaborations and Licensing Agreements
3.3 Market Challenge
3.3.1 Loss of Exclusivity, Genericization and Pricing Pressure
3.3.2 Evolving Regulatory Scenario
3.4 Impact of COVID-19
Chapter 4 Emerging Trends and Opportunities
4.1 Patient Outcomes Beyond Glucose Control
4.2 Diabetes Technology with Digital Health
4.3 Growing Trend Toward Oral Antidiabetics
4.4 Growing Focus on Accessibility and Affordability of Medicine
Chapter 5 Market Breakdown by Route of Administration and Therapy Type
5.1 Type 2 Diabetes Treatment Market by Route of Administration
5.1.1 Market Size and Forecast
5.2 Injectable Therapies Market by Type
5.2.1 Insulin Therapy
5.2.2 Glucagon-Like Peptide 1 Therapy
5.2.3 Market Size and Forecast
5.3 Oral Medications Market by Drug Class
5.3.1 Dipeptidyl Peptidase-4 Inhibitors
5.3.2 Sodium-Glucose Cotransporter-2 Inhibitors
5.3.3 Glucagon-Like Peptide 1 Receptor Agonists
5.3.4 Other Oral Antidiabetic Medications
5.3.5 Market Size and Forecast
5.4 Type 2 Diabetes Treatment Market by Therapy Type
5.4.1 Market Size and Forecast
5.5 Insulin Therapy Market by Insulin Type
5.5.1 Market Size and Forecast
5.6 Non-Insulin Therapies Market by Drug Type
5.6.1 Market Size and Forecast
Chapter 6 Market Breakdown by Region
6.1 Type 2 Diabetes Treatment Market Size by Region
6.2 North America
6.3 Europe
6.4 Asia-Pacific
6.5 Rest of the World
Chapter 7 Competitive Landscape
7.1 Global Market Shares of Leading Companies
7.2 Recent Key Developments
7.3 Blockbuster Diabetes Drug and Therapy Revenue
7.4 Facing the Patent Cliff
Chapter 8 Company Profiles
ASTRAZENECA PLC
BIOCON
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
ELI LILLY AND CO.
JANSSEN PHARMACEUTICALS INC. (JOHNSON & JOHNSON)
MERCK & CO., INC.
NOVARTIS AG
NOVO NORDISK A/S
SANOFI
Chapter 9 Project Scope and Methodology
9.1 Scope of Report
9.2 Methodology
9.3 Analyst's Credentials
9.4 BCC Custom Research
9.5 Related BCC Research Reports
List of Tables
Summary Table : Global Market for Type 2 Diabetes Treatment, by Region, Through 2027
Table 1 : Global Diabetes Estimates and Projections, 2019-2045
Table 2 : Global Prevalence of Diabetes, by Type, Through 2040
Table 3 : Age-Adjusted Comparative Prevalence of Diabetes, by Region, 2010-2040
Table 4 : First-Time Generic Drug Approvals for Type 2 Diabetes, October 2022-2021
Table 5 : Global Market for Type 2 Diabetes Treatment, by Route of Administration, Through 2027
Table 6 : Global Market for Injectable Therapies for Type 2 Diabetes, by Type, Through 2027
Table 7 : Medications in the DPP-4 Inhibitor Family
Table 8 : Medications in the SGLT2 Inhibitor Family
Table 9 : Oral GLP-1 Receptor Agonists
Table 10 : Global Market for Oral Medications for Type 2 Diabetes, by Drug Class, Through 2027
Table 11 : Global Market for Type 2 Diabetes Treatment, by Therapy Type, Through 2027
Table 12 : Insulin Types and Their Features
Table 13 : Leading Insulin Products and Their Types
Table 14 : Global Market for Insulin for Type 2 Diabetes Treatment, by Insulin Type, Through 2027
Table 15 : Global Market for Non-Insulin Therapies for Type 2 Diabetes, by Drug Type, Through 2027
Table 16 : Global Market for Type 2 Diabetes Treatment, by Region, Through 2027
Table 17 : North American Market for Type 2 Diabetes Treatment, by Route of Administration, Through 2027
Table 18 : North American Market for Injectable Therapies for Type 2 Diabetes, by Therapy Type, Through 2027
Table 19 : North American Market for Oral Medications Type 2 Diabetes, by Drug Class, Through 2027
Table 20 : North American Market for Type 2 Diabetes Treatment, by Country, Through 2027
Table 21 : European Market for Type 2 Diabetes Treatment, by Route of Administration, Through 2027
Table 22 : European Market for Injectable Therapies for Type 2 Diabetes, by Therapy Type, Through 2027
Table 23 : European Market for Oral Medications Type 2 Diabetes, by Drug Class, Through 2027
Table 24 : European Market for Type 2 Diabetes Treatment, by Country, Through 2027
Table 25 : Asia-Pacific Market for Type 2 Diabetes Treatment, by Route of Administration, Through 2027
Table 26 : Asia-Pacific Market for Injectable Therapies for Type 2 Diabetes, by Therapy Type, Through 2027
Table 27 : Asia-Pacific Market for Oral Medications Type 2 Diabetes, by Drug Class, Through 2027
Table 28 : Asia-Pacific Market for Type 2 Diabetes Treatment, by Country, Through 2027
Table 29 : RoW Market for Type 2 Diabetes Treatment, by Route of Administration, Through 2027
Table 30 : RoW Market for Injectable Therapies for Type 2 Diabetes, by Therapy Type, Through 2027
Table 31 : RoW Oral Medications Market for Type 2 Diabetes, by Drug Class, Through 2027
Table 32 : RoW Type 2 Diabetes Treatment, by Sub-Region, Through 2027
Table 33 : Global Market Shares of Type 2 Diabetes Therapies Manufacturers, 2021
Table 34 : Global Type 2 Diabetes Treatment Market, Selected Recent Key Developments, September 2019-August 2022
Table 35 : Global Sales of the Blockbuster Diabetes Drugs and Therapies, 2021
Table 36 : Blockbuster Diabetes Therapies, by Therapy Type, 2021
Table 37 : Global Evolution of the Top-Selling Diabetes Drug and Therapy Brands, 2016-2021
Table 38 : U.S. Patent Expiry Dates for the Blockbuster Diabetes Drugs, 2021
Table 39 : Astrazeneca: Product Portfolio for Type 2 Diabetes Treatment
Table 40 : Astrazeneca: Selected Key Developments, 2020-October 2022
Table 41 : Biocon: Product Portfolio for Type 2 Diabetes Treatment
Table 42 : Biocon: Selected Key Developments, 2020-October 2022
Table 43 : Boehringer Ingelheim: Products Portfolio for Type 2 Diabetes Treatment
Table 44 : Boehringer Ingelheim: Selected Key Developments, 2019-October 2022
Table 45 : Eli Lilly and Co.: Products Portfolio for Type 2 Diabetes Treatment
Table 46 : Eli Lilly and Co.: Selected Key Developments, 2020-November 2022
Table 47 : Janssen Pharmaceuticals: Products Portfolio for Type 2 Diabetes Treatment
Table 48 : Merck & Co. Inc.: Products Portfolio for Type 2 Diabetes Treatment
Table 49 : Merck & Co. Inc.: Selected Key Developments, 2020-October 2022
Table 50 : Novartis: Products Portfolio for Type 2 Diabetes Treatment
Table 51 : Novo Nordisk: Products Portfolio for Type 2 Diabetes Treatment
Table 52 : Novo Nordisk: Selected Key Developments, 2019-October 2022
Table 53 : Sanofi: Products Portfolio for Type 2 Diabetes Treatment
Table 54 : Sanofi: Selected Key Developments, 2020-November 2022
List of Figures
Summary Figure : Global Market Share of Type 2 Diabetes Treatment, by Region, 2021
Figure 1 : Type 2 Diabetes Facts
Figure 2 : Global Diabetes Incidence
Figure 3 : Risk of Developing Diabetes-Related Comorbidities
Figure 4 : Global Market Shares of Type 2 Diabetes Treatment, by Route of Administration, 2021
Figure 5 : Global Market Shares of Injectable Therapies for Type 2 Diabetes, by Type, 2021
Figure 6 : Global Market Shares of Oral Medications for Type 2 Diabetes, by Drug Class, 2021
Figure 7 : Global Market Shares of Type 2 Diabetes Treatment, by Therapy Type, 2021
Figure 8 : Global Market Shares of Insulin for Type 2 Diabetes Treatment, by Insulin Type, 2021
Figure 9 : Global Market Shares of Non-Insulin Therapies for Type 2 Diabetes, by Drug Type, 2021
Figure 10 : Global Type 2 Diabetes Treatment Market, by Region
Figure 11 : Global Market Share of Type 2 Diabetes Treatment, by Region, 2021
Figure 12 : Global Market Shares of Type 2 Diabetes Treatment, by Region, 2027
Figure 13 : Global Market Shares of Type 2 Diabetes Therapies Manufacturers, 2021
Figure 14 : Global Evolution of the Top-Selling Insulin Brands, 2016-2021
Figure 15 : Global Evolution of the Top-Selling Non-Insulin Diabetes Drug Brands, 2016-2021
Global Metformin Hydrochloride Market Research Report 2024
Published: 08-Jan-2024 Price: US 2900 Onwards Pages: 104
Metformin hydrochloride is The raw material of finished product metformin hydrochloride drugs. That is The API metformin hydrochloride. Metformin Hydrochloride finished product is an oral antihyperglycemic drug used in The management of type 2-diabetes. Metformin hydrochloride (N, N-dimethylimidodicarbonimidic diamide hydrochloride) is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents.
Metformin hydrochloride is a white to off-white crystall......
Global Antidiabetic Sulphonylureas Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 04-Jan-2024 Price: US 3380 Onwards Pages: 112
Market Overview of Global Antidiabetic Sulphonylureas market:
According to our latest research, the global Antidiabetic Sulphonylureas market looks promising in the next 5 years. As of 2022, the global Antidiabetic Sulphonylureas market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of t......
Global Insulin Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 101
According to our LPI (LP Information) latest study, the global Insulin market size was valued at US$ million in 2023. With growing demand in downstream market, the Insulin is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Insulin market. Insulin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization......
Global Insulin API Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 116
According to our LPI (LP Information) latest study, the global Insulin API market size was valued at US$ 1707.6 million in 2023. With growing demand in downstream market, the Insulin API is forecast to a readjusted size of US$ 2101.4 million by 2030 with a CAGR of 3.0% during review period.
The research report highlights the growth potential of the global Insulin API market. Insulin API are expected to show stable growth in the future market. However, product differentiation, reducing co......
Global Glucagon Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 101
According to our LPI (LP Information) latest study, the global Glucagon market size was valued at US$ 543.9 million in 2023. With growing demand in downstream market, the Glucagon is forecast to a readjusted size of US$ 835.7 million by 2030 with a CAGR of 6.3% during review period.
The research report highlights the growth potential of the global Glucagon market. Glucagon are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......
Global Acarbose Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 95
According to our LPI (LP Information) latest study, the global Acarbose market size was valued at US$ 135.8 million in 2023. With growing demand in downstream market, the Acarbose is forecast to a readjusted size of US$ 165.9 million by 2030 with a CAGR of 2.9% during review period.
The research report highlights the growth potential of the global Acarbose market. Acarbose are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......
Global Insulin Glargine Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 77
According to our LPI (LP Information) latest study, the global Insulin Glargine market size was valued at US$ 6562.1 million in 2023. With growing demand in downstream market, the Insulin Glargine is forecast to a readjusted size of US$ 8722.5 million by 2030 with a CAGR of 4.1% during review period.
The research report highlights the growth potential of the global Insulin Glargine market. Insulin Glargine are expected to show stable growth in the future market. However, product differen......
Global Liraglutide Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 103
According to our LPI (LP Information) latest study, the global Liraglutide market size was valued at US$ million in 2023. With growing demand in downstream market, the Liraglutide is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Liraglutide market. Liraglutide are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ch......
Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 96
According to our LPI (LP Information) latest study, the global Glucagon Like Peptide-1 (GLP-1) Agonists market size was valued at US$ 8624.4 million in 2023. With growing demand in downstream market, the Glucagon Like Peptide-1 (GLP-1) Agonists is forecast to a readjusted size of US$ 21310 million by 2030 with a CAGR of 13.8% during review period.
The research report highlights the growth potential of the global Glucagon Like Peptide-1 (GLP-1) Agonists market. Glucagon Like Peptide-1 (GL......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
